These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 39431656)
1. Association of Khalouei A; Masoumi-Ardakani Y; Jafarzaheh A; Kalantari Khandani B; Sedghy F; Khosravi Mashizi A; Yaghoobi MM; Zangouey M; Shahouzehi B J Res Health Sci; 2024 Sep; 24(4):e00631. PubMed ID: 39431656 [TBL] [Abstract][Full Text] [Related]
2. Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer. Gao H; Ge RC; Liu HY; Wang Y; Yan S Genet Mol Res; 2014 Oct; 13(4):8997-9004. PubMed ID: 25366790 [TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in ERCC1 and XPF gene and response to chemotherapy and overall survival of non-small cell lung cancer. Shi ZH; Shi GY; Liu LG Int J Clin Exp Pathol; 2015; 8(3):3132-7. PubMed ID: 26045829 [TBL] [Abstract][Full Text] [Related]
4. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort. Bao Y; Yang B; Zhao J; Shen S; Gao J Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy. Mo J; Luo M; Cui J; Zhou S Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845 [TBL] [Abstract][Full Text] [Related]
6. Polymorphisms in ERCC1 gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients. Zhao X; Zhang Z; Yuan Y; Yuan X Tumour Biol; 2014 Aug; 35(8):8335-41. PubMed ID: 24859833 [TBL] [Abstract][Full Text] [Related]
7. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression. Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383 [TBL] [Abstract][Full Text] [Related]
8. The Significant Interaction of Excision Repair Cross-complementing Group 1 Genotypes and Smoking to Lung Cancer Risk. Chen LH; Shen TC; Li CH; Chiu KL; Hsiau YC; Wang YC; Gong CL; Wang ZH; Chang WS; Tsai CW; Hsia TC; Bau DT Cancer Genomics Proteomics; 2020; 17(5):571-577. PubMed ID: 32859635 [TBL] [Abstract][Full Text] [Related]
9. Contribution of excision repair cross-complementing group 1 genotypes to triple negative breast cancer risk. Tsai CW; Chang WS; Shen TC; Su CH; Wang HC; Liu LC; Bau DT PLoS One; 2018; 13(8):e0202112. PubMed ID: 30096175 [TBL] [Abstract][Full Text] [Related]
10. Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients. Takenaka T; Yano T; Kiyohara C; Miura N; Kouso H; Ohba T; Kometani T; Shoji F; Yoshino I; Maehara Y Lung Cancer; 2010 Jan; 67(1):101-7. PubMed ID: 19361884 [TBL] [Abstract][Full Text] [Related]
11. The determination of relationship between "excision repair cross-complementing group 1" (ERCC1) gene T19007C and C8092A single nucleotide polymorphisms and clinicopathological parameters in non-small cell lung cancer. Koç E; Caner V; Büyükpınarbaşılı N; Tepeli E; Türk NS; Ozan Çetin G; Bağcı G Mol Biol Rep; 2012 Jan; 39(1):375-80. PubMed ID: 21553053 [TBL] [Abstract][Full Text] [Related]
12. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer. Zhao F; Shang Y; Zeng C; Gao D; Li K Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894 [TBL] [Abstract][Full Text] [Related]
13. Promoter polymorphisms of TOP2A and ERCC1 genes as predictive factors for chemotherapy in non-small cell lung cancer patients. Grenda A; Błach J; Szczyrek M; Krawczyk P; Nicoś M; Kuźnar Kamińska B; Jakimiec M; Balicka G; Chmielewska I; Batura-Gabryel H; Sawicki M; Milanowski J Cancer Med; 2020 Jan; 9(2):605-614. PubMed ID: 31797573 [TBL] [Abstract][Full Text] [Related]
14. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies. Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132 [TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in ERCC1 and ERCC2/XPD genes and carcinogen DNA adducts in human lung. Lee MS; Liu CY; Su L; Christiani DC Lung Cancer; 2015 Jul; 89(1):8-12. PubMed ID: 26001533 [TBL] [Abstract][Full Text] [Related]
16. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy]. Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563 [TBL] [Abstract][Full Text] [Related]
17. Genetic variability of genes in NER pathway influences the treatment outcome of gastric cancer. Xue MH; Li GY; Wu XJ; Zhang CX; Zhang CF; Zhu KX Int J Clin Exp Pathol; 2015; 8(5):5563-9. PubMed ID: 26191265 [TBL] [Abstract][Full Text] [Related]
18. The Contribution of Excision Repair Cross-complementing Group 1 Genotypes to Colorectal Cancer Susceptibility in Taiwan. Yueh TC; Chou AK; Gong CL; Fu CK; Pei JS; Wu MH; Tsai CW; Chang WS; Hsiao CL; Yen ST; Li HT; Bau DT Anticancer Res; 2017 May; 37(5):2307-2313. PubMed ID: 28476796 [TBL] [Abstract][Full Text] [Related]
19. Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer. Du Y; Su T; Zhao L; Tan X; Chang W; Zhang H; Cao G PLoS One; 2014; 9(6):e99843. PubMed ID: 24933103 [TBL] [Abstract][Full Text] [Related]
20. Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use. Hou R; Liu Y; Feng Y; Sun L; Shu Z; Zhao J; Yang S Gene; 2014 Sep; 548(1):1-5. PubMed ID: 24861646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]